Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intermediate filaments]

T Hirasawa1, M Yasuda, Y Osamura

  • 1Department of Obstetrics and Gynecology, School of Medicine, Tokai University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats.

Liver·1998
Same author

[Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1998
Same author

Effect of additives on refolding of a denatured protein.

Biotechnology progress·1998
Same author

Electrohydraulic lithotripsy treatment for persimmon bezoars.

Endoscopy·1998
Same author

Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1.

Clinical rheumatology·1998
Same author

A comparative study of germinal center: fowls and mammals.

Comparative immunology, microbiology and infectious diseases·1998
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Antibodies targeting intermediate filaments like keratin and vimentin are crucial for diagnosing tumors. Immunohistochemistry reveals altered filament localization in neoplastic cells, aiding in tumor origin identification.

Area of Science:

  • Pathology
  • Cell Biology
  • Immunohistochemistry

Context:

  • Intermediate filaments (keratin, vimentin, desmin, GFAP, neurofilaments) are vital cellular structural proteins.
  • Immunohistochemistry (IHC) is a key diagnostic technique in surgical pathology.
  • Neoplastic transformation often alters cellular protein expression and localization.

Purpose:

  • To highlight the utility of intermediate filament antibodies in tumor diagnosis.
  • To explain how altered immunolocalization of intermediate filaments aids in identifying tumor cell characteristics and origin.
  • To discuss the diagnostic significance and challenges of "variant" tumor expressions.

Summary:

  • Antibodies against intermediate filaments (keratins, vimentin, desmin, GFAP, neurofilaments) are indispensable tools in immunohistochemistry for tumor diagnosis.

Related Experiment Videos

  • Altered immunolocalization of these filaments within tumor cells provides critical diagnostic information regarding cell of origin (epithelial vs. non-epithelial).
  • While generally reliable, "variant" expressions (e.g., vimentin in epithelial tumors) necessitate careful interpretation, underscoring the complexity of IHC in pathology.

    • Impact:

    • Enhances diagnostic accuracy in surgical pathology by providing definitive tumor markers.
    • Facilitates a deeper understanding of the relationship between tumor cell morphology and function.
    • Improves the classification of tumors, particularly in challenging or "variant" cases.